European Medicines Agency says modified Covid vaccine needed to combat new variant
NL Times -

A new variant of the coronavirus has become dominant, supplanting other versions of the virus. This is why the Emergency Task Force of the European Medicines Agency (EMA) in Amsterdam issued a statement on Tuesday advising that the Covid-19 vaccine be adapted ahead of vaccination campaigns organized by EU Member States this year and next, beginning with vaccination rounds in the autumn.

Related Articles

Latest in News

More from NL Times